5Schmitt J, Wozel G. The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis [ J ]. Dermatology,2005,210 ( 3 ) : 194 - 199.
6Halberg F, Cornelissen G, O tsuka K, et al. Essays on chronomics spawned by transd isciplinary chronobiology [ J]. Neuroendoc rinollett, 2001, 22 (5) : 359 -384.
70sishi K. Shiota M . Sakamoto K, et al Feeding is not amore potent zeitgeber than the light-dark cycle in Drosophila [ J ] Neuroreport, 2004,22 ; 15 (4) :739 - 743.
8Chaudhari U, Romano P, Mulcahy LD, et al. Efficacy and safetyof infliximab monotherapy for plaque - type psoriasis: a randomised trial[J]. Lancet, 2001, 357 (9271) :1842-1847.
9Gisondi P, Gubinelli E, Cocuroccia B, et al. Targeting Tumor Necrosis Factor - alpha in the Therapy of Psoriasis [J]. CurrDrug Targets Inflamm Allergy, 2004, 3 (2) : 175 - 183.
10Schottelius AJ, Moldawer LL, Dinarello CA, et al. Biology oftumor necrosis factor - alpha - imp lications for psoriasis[J]. Exp Dermatol, 2004, 13 (4) :193-222.
